Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
57,463,700
-
Share change
-
-165,099
-
Total reported value
-
$6,133,341,626
-
Put/Call ratio
-
98%
-
Price per share
-
$106.73
-
Number of holders
-
451
-
Value change
-
-$38,433,148
-
Number of buys
-
213
-
Number of sells
-
245
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2024
As of 30 Jun 2024 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 451 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 57,463,700 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., LSV ASSET MANAGEMENT, Capital World Investors, STATE STREET CORP, Pacer Advisors, Inc., JPMORGAN CHASE & CO, Vestal Point Capital, LP, AMERIPRISE FINANCIAL INC, and Polaris Capital Management, LLC.
This table shows 451 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.